RhumbLine Advisers
KIN

RhumbLine Advisers’s Kindred Biosciences, Inc. KIN Stock Holding History

RhumbLine Advisers’s Portfolio KIN Stock Details KIN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-46,782
Closed -$233K – 3182
2021
Q1 		$233K Sell
46,782
-1,870
-4% -$9.03K ﹤0.01% 2789
2020
Q4 		$210K Buy
48,652
+3,640
+8% +$14.8K ﹤0.01% 2821
2020
Q3 		$193K Sell
45,012
-5,350
-11% -$22.4K ﹤0.01% 2702
2020
Q2 		$226K Buy
50,362
+2,350
+5% +$10.5K ﹤0.01% 2717
2020
Q1 		$192K Hold
48,012
– – ﹤0.01% 2599
2019
Q4 		$407K Buy
48,012
+329
+0.7% +$2.57K ﹤0.01% 2460
2019
Q3 		$327K Sell
47,683
-375
-0.8% -$2.75K ﹤0.01% 2535
2019
Q2 		$400K Buy
48,058
+4,740
+11% +$40.9K ﹤0.01% 2456
2019
Q1 		$397K Buy
43,318
+3,477
+9% +$35.3K ﹤0.01% 2424
2018
Q4 		$436K Buy
39,841
+15,128
+61% +$191K ﹤0.01% 2360
2018
Q3 		$345K Buy
24,713
+322
+1% +$4.36K ﹤0.01% 2450
2018
Q2 		$260K Buy
24,391
+1,626
+7% +$15.9K ﹤0.01% 2603
2018
Q1 		$197K Buy
22,765
+2,275
+11% +$20K ﹤0.01% 2609
2017
Q4 		$194K Sell
20,490
-3,639
-15% -$28.4K ﹤0.01% 2643
2017
Q3 		$189K Buy
24,129
+1,280
+6% +$9.61K ﹤0.01% 2764
2017
Q2 		$197K Buy
+22,849
New +$164K ﹤0.01% 2766

Other funds holding KIN

PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return

RhumbLine Advisers's KIN Position: Q2 2021 in Review

RhumbLine Advisers sold out of Kindred Biosciences, Inc. (KIN) in Q2 2021, closing a stake of 46,782 shares — an estimated $233K sold.

RhumbLine Advisers first reported a position in KIN in Q2 2017 and held it in 16 quarters. The position peaked at $436K in Q4 2018. 87 funds tracked by Wall St. Rank hold KIN as of Q2 2021.

  • RhumbLine Advisers reported no remaining Kindred Biosciences, Inc. position as of Q2 2021 after selling out during the quarter.
  • RhumbLine Advisers sold 46,782 Kindred Biosciences, Inc. shares in Q2 2021, an estimated $233K.
  • RhumbLine Advisers first reported a position in Kindred Biosciences, Inc. in Q2 2017 and held it in 16 quarters.
  • RhumbLine Advisers's Kindred Biosciences, Inc. position peaked at $436K in Q4 2018.
  • 87 funds tracked by Wall St. Rank held Kindred Biosciences, Inc. as of Q2 2021.

Based on RhumbLine Advisers's 13F filing for Q2 2021, filed 5 Aug 2021.